ARTICLE | Company News
Draxis receives Canadian approval
July 31, 2001 7:00 AM UTC
Draxis (TSE:DAX; DRAX) subsidiary Draximage received manufacturing and marketing approval in Canada for its BrachySeed palladium-103 radiotherapy implant to treat prostate cancer and other selected ca...